\BOOKMARK [0][-]{chapter.7}{Discussion}{}% 188
\BOOKMARK [1][-]{section.7.1}{Synthetic Lethality and CDH1 Biology}{chapter.7}% 189
\BOOKMARK [2][-]{subsection.7.1.1}{Established Functions of CDH1}{section.7.1}% 190
\BOOKMARK [2][-]{subsection.7.1.2}{The Molecular Role of CDH1 in Cancer}{section.7.1}% 191
\BOOKMARK [1][-]{section.7.2}{Significance}{chapter.7}% 192
\BOOKMARK [2][-]{subsection.7.2.1}{Synthetic Lethality in the Genomic Era}{section.7.2}% 193
\BOOKMARK [2][-]{subsection.7.2.2}{Clinical Interventions based on Synthetic Lethality}{section.7.2}% 194
\BOOKMARK [1][-]{section.7.3}{Evaluating the Synthetic Lethality Prediction Tool}{chapter.7}% 195
\BOOKMARK [2][-]{subsection.7.3.1}{Strength of the Synthetic Lethality Prediction Tool}{section.7.3}% 196
\BOOKMARK [2][-]{subsection.7.3.2}{Limitations of the Synthetic Lethality Prediction Tool}{section.7.3}% 197
\BOOKMARK [2][-]{subsection.7.3.3}{Comparisons to Alternative Methods}{section.7.3}% 198
\BOOKMARK [3][-]{subsubsection.7.3.3.1}{Combined with Experimental Screening}{subsection.7.3.3}% 199
\BOOKMARK [3][-]{subsubsection.7.3.3.2}{Differences to Computational Methods}{subsection.7.3.3}% 200
\BOOKMARK [1][-]{section.7.4}{Future Directions}{chapter.7}% 201
\BOOKMARK [2][-]{subsection.7.4.1}{Refinements Synthetic Lethality Prediction Methods}{section.7.4}% 202
\BOOKMARK [3][-]{subsubsection.7.4.1.1}{Wider Use of Synthetic Lethality Prediction}{subsection.7.4.1}% 203
\BOOKMARK [2][-]{subsection.7.4.2}{Validation of Synthetic Lethal Genes and Pathways}{section.7.4}% 204
\BOOKMARK [3][-]{subsubsection.7.4.2.1}{Pre-clinical and Clinical Testing}{subsection.7.4.2}% 205
\BOOKMARK [2][-]{subsection.7.4.3}{Application to Further Genes and Pathways}{section.7.4}% 206
\BOOKMARK [0][-]{chapter.8}{Conclusion}{}% 207
\BOOKMARK [0][-]{section*.5}{References}{}% 208
